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Circadian rhythms govern interorgan coordination and harmonize internal function with the external environment. Agerelated changes in circadian rhythms are associated with a
diverse array of diseases including neurological disorders [1].
Moreover, circadian dysfunction occurs prior to symptoms in
some conditions such as Alzheimer disease, suggesting a potential target for intervention [2, 3].
Current methods for circadian measurement in humans
have lower granularity or are logistically constrained. Dim light
melatonin onset, the “gold-standard” measure of circadian
phase, requires timed dim light conditions. Actigraphy is influenced by extra-circadian behaviors and is challenging in people
with limited mobility. However, newer approaches using transcriptional biomarkers may provide more granular and objective
information about circadian function.
TimeSignature (TS) is an algorithm that estimates internal
circadian time from gene expression in whole blood [4]. In
healthy young adults, TS accuracy is maintained using as few as
two suitably spaced blood samples. An additional advantage includes robust accuracy across study populations, protocols, and
assay platforms [4]. However, there are no studies evaluating
TS performance in older adults. In this study, we applied TS to
whole-blood RNA sequencing (RNA-Seq) data from older adults
and examined associations with several standard methods of
circadian assessment.

All participant procedures were approved by the Washington
University Human Research Protection Office. Written, informed
consent was obtained from community-dwelling adults aged
>65 years. Exclusion criteria were neurological disorders or
contraindications to study procedures. Participants completed
the Horne-Ostberg Morningness–Eveningness Questionnaire
(MEQ) and were categorized as “morning type” (MEQ >59),
“intermediate type” (MEQ 42–58), or “evening type” (MEQ <41)
[5]. Participants wore actigraphs on the nondominant wrist
while keeping a sleep diary, for 5–14 days at home. Then, at an
overnight study visit, they provided saliva samples via passive
drool method hourly from 6 pm until bedtime in a dim (<30
lux) environment. Saliva samples were immediately frozen at
−20°C. Blood was collected by venipuncture at ~8 pm and ~10
am the next morning into EDTA tubes and then PAXgene RNA
tubes. EDTA tubes were immediately placed on ice until centrifugation within 1 hour, followed by plasma-aliquoting and
freezing/storage at −80°C. PAXgene RNA tubes were frozen per
manufacturer’s protocol.
RNA was isolated using the PAXgene Blood RNA extraction kit (Qiagen), and library preparation was performed using
ribosomal and globin depletion methods (Qiagen FastSelect
[H/M/R+Globin]). Bulk RNA-Seq was performed on an Illumina
NovaSeq S4 at 50 million reads/sample. Transcripts were processed with bcl2fastq, STAR (using Ensembl release 76), Subread,
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characteristic curve reached 0.81 (Figure 1A), consistent with
previously published data from young adults [4]. A significant
correlation between intraindividual AM and PM Transcriptomic
Angles (r = 0.797, p < 0.001) was also observed, demonstrating internal consistency of the measurements (data not shown).
We hypothesized that individuals with a positive
Transcriptomic Angle would have an advanced circadian phase
(morning type). Accordingly, Transcriptomic Angle negatively
correlated with actigraphically assessed wake time, M10, and
bedtime (Figure 1B). A negative correlation was also observed
between Transcriptomic Angle and DLMO, the “gold-standard”
measure of circadian phase, and with subjective chronotype, as
assessed by the MEQ. By contrast, other sleep-related variables
and measures of circadian amplitude or fragmentation were not
correlated with Transcriptomic Angle (Figure 1B and data not
shown). Bland–Altman plots demonstrate general agreement
between Transcriptomic Angle and standard measurement
techniques (Figure 1B).
In this study, we demonstrate TS accuracy in older adults
without the need for algorithm retraining. Moreover, we found
that TS-derived Transcriptomic Angle correlates with 3 separate
measures of circadian phase including actigraphy, DLMO, and
MEQ. Therefore, TS output may allow for transcriptomic circadian phenotyping, which would be useful for clinical and neurological research applications. For example, the delayed circadian
phase has been linked to dementia and Alzheimer disease pathology [9, 10], but accurate chronotyping is needed in longitudinal
cohort studies to further examine this relationship.
Future work will focus on TS optimization for the assessment of circadian amplitude and fragmentation, and a more diverse cohort will be needed for generalizability. We note the lack
of “evening types” in our cohort. However, evening chronotypes
are rare among older adults, and the accuracy of TS trained with
data from young adults (who tend to have later chronotypes)

Table 1. Participant demographics and clinical characteristics stratified by Morningness–Eveningness Questionnaire (MEQ) chronotype
Variables

Total

Morning type

Intermediate type

Number (n)
Demographics
Age (y)
Female sex (%)
Caucasian race (%)
Body mass index (kg/m2)
Circadian measures, nonactigraphic
Dim Light Melatonin Onset (time ± min)
Total MEQ score
Transcriptomic Angle (hours)
Actigraphy circadian measures
M10 (time ± min)
Amplitude
Interdaily stability
Intradaily variability
Actigraphy sleep measures
Bedtime (time ± min)
Midsleep (time ± min)
Waketime (time ± min)
Total sleep time (hh:mm ± min)
Sleep efficiency (%)
Wake time after sleep onset (min)

40

28

12

71.2 ± 4.2
21 (53%)
38 (95%)
29.1 ± 6.7

71.1 ± 4.6
17 (60%)
26 (93%)
28.9 ± 7.0

71.3 ± 3.3
4 (33%)
12 (100%)
29.5 ± 6.1

08:37 pm ± 92
64.4 ± 10.1
2.05 ± 1.72

08:10 pm ± 77*
69.7 ± 6.3*
2.69 ± 1.38*

09:42 pm ± 99*
52.0 ± 5.1*
0.56 ± 1.52*

08:19 am ± 108
279 ± 114
0.58 ± 0.14
0.83 ± 0.22

07:51 am ± 110*
276 ± 114
0.59 ± 0.14
0.85 ± 0.24

09:22 am ± 71*
287 ± 118
0.58 ± 0.14
0.78 ± 0.18

10:45 pm ± 68
04:10 am ± 27
07:05 am ± 76
06:43 ± 54
81 ± 8
60 ± 24

10:20 pm ± 53*
04:07 am ± 24
06:33 am ± 63*
06:40 ± 51
81 ± 7
58 ± 19

11:42 pm ± 65*
04:18 am ± 33
08:18 am ± 49*
06:47 ± 63
80 ± 12
65 ± 32

All continuous variables are shown as mean +standard deviation. M10, start time of most active 10 h.
*p < 0.05 by Student’s t-test or chi-squared test comparing morning versus intermediate type.
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Salmon, EdgeR5, and custom Python scripts. RSeQC was used for
quality control. An existing microarray data set was used for TS
training before TS application as previously described [4]. The
time predicted by TS is the “Transcriptomic Time.” The difference between Transcriptomic Time and True Time of sampling,
or the “Transcriptomic Angle,” was calculated separately for AM
and PM samples for each participant, then averaged.
For non-TS circadian assessment, saliva and plasma melatonin levels were assayed with commercial kits (Buhlmann
Melatonin RIA or ELISA). Melatonin plots were visually inspected, and those with a typical “hockey stick” shape were
included [6]. Mean saliva:plasma melatonin ratios were calculated to establish assay-specific thresholds equivalent to plasma
melatonin levels of 10 pg/mL. DLMO was calculated by linear
interpolation. Actigraphy data were processed using Actiware
(Philips-Respironics) and Clocklab (Actimetrics) as previously
described [3, 7, 8]. Sleep variables included those of timing (bedtime, waketime, and midsleep), quantity (total sleep time), and
quality (sleep efficiency, wake time after sleep onset). Circadian
variables included those of phase: M10 (indicating the start
time of the most active 10 hours), amplitude, intradaily variability, and interdaily stability. Statistical analysis included tests
of normality by visual inspection and Kolmogorov–Smirnov
test. Student’s t-tests and chi-squared tests were used to compare two groups. Bland–Altman plots were generated between
Transcriptomic Angle and other variables. Pearson correlations
were used for associations and partial correlations for adjustment for age and sex, all in R.
Forty participants (71.2 ± 4.2 years) were included (Table
1) and stratified by MEQ score. As expected, waketime, bedtime, M10, and DLMO were earlier for “morning type” participants. To evaluate TS accuracy, we compared the TS-derived
Transcriptomic Time to the True Time of blood sampling. The
normalized area under the curve (nAUC) of the receiver operator
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suggests that TS would perform similarly [4]. Overall, the
increasing use of circadian transcriptomics approaches to
measure physiological states points towards precision medicine
as a tangible reality in the future.
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